Echomet Pharmaceuticals Private Limited
About Echomet Pharmaceuticals Private Limited
Data last updated:
Echomet Pharmaceuticals Private Limited is a private limited company based in Ranchi, Jharkhand, India. It was incorporated on 31 July 2023.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U46497JH2023PTC020952.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kawish Hoda and Nisha Kumari Lohra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ranchi, Jharkhand.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.77 Lakh. For the same year it recorded a net profit of ₹6,200 (net margin 3.5%) and EBITDA of ₹15,641 (EBITDA margin 8.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Shahina Tabassum, Sattar Colony Lane No – 3, Ranchi, Jharkhand, India – 834009
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Echomet Pharmaceuticals Private Limited
The main business activity of Echomet Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Echomet Pharmaceuticals Private Limited FY 2025 filings available
Echomet Pharmaceuticals Private Limited reported revenue of ₹1.77 Lakh for FY 2025.
Financial Statement Summary of Echomet Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹15,641 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹6,200 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Echomet Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 8.9% | •••• |
| Net Profit Margin | 3.5% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Echomet Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Echomet Pharmaceuticals Private Limited
Echomet Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kawish Hoda | Director | 31 Jul 2023 | 3 Years 2 Months | Current |
| Nisha Kumari Lohra | Director | 22 Jan 2025 | 1 Years 8 Months | Current |
Peer Comparison of Echomet Pharmaceuticals Private Limited
Echomet Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Strikar Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2019) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Sirois Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2024) | •••• | •••• | 2540843.0% | •••• | Dehradun, Uttarakhand, India |
| Hartwin Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Airiza Pharmaceuticals Private Limited | ₹1.77 Lakh (FY 2022) | •••• | •••• | -17.0% | •••• | Asansol, West Bengal, India |
| Goldman Pharmaceuticals Private Limited | ₹1.77 Lakh (FY 2025) | •••• | •••• | •••• | Ghaziabad, Uttar Pradesh, India | |
| Echomet Pharmaceuticals Private Limited this company | ₹1.77 Lakh (FY 2025) | •••• | •••• | •••• | Ranchi, Jharkhand, India | |
| Proxima Pharmaceuticals Marketing Private Limited | ₹1.76 Lakh (FY 2020) | •••• | •••• | 11.0% | •••• | Bhopal, Madhya Pradesh, India |
| Brinj Pharmaceuticals Private Limited | ₹1.76 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Shivpuri, Patna, Bihar, India |
| Mexicare India Pharmaceuticals Private Limited | ₹1.76 Lakh (FY 2016) | •••• | •••• | •••• | Thiruvananthapuram, Kerala, India | |
| Omkam Pharmaceuticals Private Limited | ₹1.75 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | New Delhi, Delhi, India |
| Kokban Ayurvedic Pharmaceuticals Private Limited | ₹1.74 Lakh (FY 2018) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Echomet Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Echomet Pharmaceuticals Private Limited
Echomet Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Echomet Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Echomet Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Echomet Pharmaceuticals Private Limited
Echomet Pharmaceuticals Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Gaurav Kumar ceased to be Director on 24 Jan 2025.
Credit Ratings, Litigation & Regulatory Alerts for Echomet Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Echomet Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Echomet Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Echomet Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Echomet Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Echomet Pharmaceuticals Private Limited
Echomet Pharmaceuticals is an active private limited company based in Ranchi, Jharkhand, India. It was incorporated on 31 July 2023 (3+ years old) and is registered under CIN U46497JH2023PTC020952.
Echomet Pharmaceuticals reported revenue of ₹1.77 Lakh for FY 2025.
Echomet Pharmaceuticals has 2 current directors:
- Kawish Hoda - Director
- Nisha Kumari Lohra - Director
Echomet Pharmaceuticals reported a net profit of ₹6,200 (net margin 3.5%) and EBITDA of ₹15,641 (EBITDA margin 8.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Echomet Pharmaceuticals is U46497JH2023PTC020952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Echomet Pharmaceuticals was incorporated on 31 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Echomet Pharmaceuticals by revenue are Strikar Pharmaceuticals Private Limited, Sirois Pharmaceuticals Private Limited, Hartwin Pharmaceuticals Private Limited, Airiza Pharmaceuticals Private Limited, Goldman Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Gaurav Kumar ceased to be Director on 24 Jan 2025. Nisha Kumari Lohra was appointed as Director on 22 Jan 2025. Gaurav Kumar was appointed as Director on 31 Jul 2023. Echomet Pharmaceuticals has 4 board changes on record in total.
The registered office of Echomet Pharmaceuticals is at CO Shahina Tabassum, Sattar Colony Lane No – 3, Ranchi, Jharkhand, India – 834009.
Echomet Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
No. Echomet Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.